What is the recommended treatment approach for a patient with thyroid orbitopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Thyroid Orbitopathy

A multidisciplinary approach combining endocrinology, oculoplastics, and neuro-ophthalmology is recommended for thyroid eye disease management, with treatment sequenced based on disease activity and severity. 1

Initial Assessment and Risk Factor Modification

Disease activity must be determined before initiating treatment, as this fundamentally changes the therapeutic approach:

  • Clinical Activity Score (CAS) ≥3 indicates active inflammation requiring immunosuppressive therapy, while inactive disease requires only symptomatic management or surgical rehabilitation 2
  • Smoking cessation is mandatory as it significantly increases both risk and severity of thyroid orbitopathy 2, 3
  • Achieve and maintain euthyroid state rapidly through coordination with endocrinology, as adequately controlled thyroid function improves orbitopathy outcomes 3, 4
  • Avoid radioactive iodine treatment during active orbitopathy as it can worsen the eye disease 4

Treatment Based on Disease Severity

Mild Disease (No Diplopia in Primary/Reading Position)

  • Observation is appropriate if there is no diplopia in primary gaze or reading position 1
  • Symptomatic management includes artificial tears for exposure symptoms and selenium supplementation 5, 3
  • Monitor for disease progression with serial examinations 6

Moderate-to-Severe Active Disease (CAS ≥5)

  • Teprotumumab is the preferred treatment for active moderate-to-severe disease, reducing proptosis and CAS scores 2
  • Intravenous corticosteroids (methylprednisolone with cumulative doses around 3-4 grams over 6-12 weeks) are effective for active inflammation 5, 3
  • Orbital radiation therapy may be combined with corticosteroids in select cases 3, 4
  • Critical caveat: Assess for pre-existing hearing loss before teprotumumab and counsel patients about permanent hearing risk 2

Sight-Threatening Disease

  • Emergency orbital decompression is required for compressive optic neuropathy or severe exposure keratopathy threatening vision 2, 3
  • Do not delay surgical intervention when vision is threatened 7

Surgical Rehabilitation Sequence (After Disease Quiescence)

Surgery should be delayed until the inflammatory stage has subsided and the angle of deviation has been stable for at least 6 months, though earlier surgery in select patients can have satisfactory outcomes 1

The surgical sequence must follow this order:

  1. Orbital decompression first (if needed for proptosis) 1
  2. Strabismus surgery second to address diplopia, as decompression can worsen or create new strabismus 1
  3. Eyelid surgery last to correct retraction, as earlier surgeries affect lid position 1, 3

Strabismus Surgery Considerations

  • Recession of restricted muscles is the mainstay of surgical correction; resection is generally avoided in restrictive disease 1
  • Vertical deviations are more challenging than horizontal deviations (66% vs 84% success after primary surgery) because the inferior rectus muscle is most commonly affected 1
  • Systematic preoperative and intraoperative assessment of forced ductions and ocular torsion minimizes undesired outcomes 1
  • Recession of inferior rectus muscle carries specific risks: lower lid retraction, consecutive hypertropia, and A-pattern exotropia in downgaze 1
  • Consider orbital decompression consultation before strabismus surgery in patients with concurrent significant proptosis, as muscle recession predictably worsens proptosis 1

Technical Surgical Details

  • Absorbable sutures (6-0 polyglactin) are generally preferred for muscle isolation and reattachment 1
  • Non-absorbable sutures may reduce postoperative drift in large inferior rectus recessions 1
  • Adjustable suture technique remains controversial: some surgeons report better success while others avoid it due to overcorrection and muscle slippage concerns 1
  • Thyroid eye disease is the most common risk factor for pulled-in-two syndrome (spontaneous horizontal muscle transection during surgery), requiring careful surgical technique 1

Nonsurgical Diplopia Management

  • Fresnel or ground-in prisms provide temporary relief while awaiting definitive treatment or for small residual deviations 1
  • Chemodenervation during active phase may provide temporary diplopia relief and possibly reduce final misalignment 1

Provider Requirements

Management requires an experienced ophthalmologist comfortable with complex strabismus and severe restrictive disease, with orthoptists providing valuable assistance under supervision 1

Common Pitfalls to Avoid

  • Do not perform strabismus surgery during active inflammation as the deviation will continue to change 1
  • Do not perform eyelid surgery before strabismus repair as muscle surgery affects lid position 1
  • Do not underestimate the complexity of vertical deviations in thyroid eye disease, particularly inferior rectus involvement 1
  • Do not forget preoperative counseling about potential worsening of proptosis with muscle recession surgery 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Thyroid Eye Disease Characteristics and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Optimal management of Graves orbitopathy: a multidisciplinary approach.

The Netherlands journal of medicine, 2011

Research

Clinical assessment of thyroid related orbitopathy: a review.

Pediatric endocrinology reviews : PER, 2010

Research

[Thyroid orbitopathy (pathogenesis, diagnosis and treatment)].

Archivos de la Sociedad Espanola de Oftalmologia, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.